ScreenerHero

LITS Lite Strategy, Inc.

NAS · US · Healthcare · Biotechnology · litestrategy.com
1.270USD-9.93%Mkt Cap: 38.62M $P/E: —

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed it…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap38.62M USD
Enterprise Value37.17M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-15.95M USD
Revenue/Share—
Last Price1.270 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG2.22
EV/EBITDA-3.18
EV/Revenue—
P/S—
P/B0.87
EPS (TTM)-2.07
EPS (Forward)—
52W Range
0.688825% of range2.970
52W High2.970 USD
52W Low0.6888 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-94.18%
ROA-87.20%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.84M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-17.35%
Net Debt-5.71M USD
Net Debt/EBITDA0.49
Balance Sheet
Debt/Equity—
Current Ratio5.75
Quick Ratio5.34
Book Value/Sh1.62 USD
Cash/Share0.19 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateNov 16, 2023
Pay DateDec 6, 2023
Splits
Last Split1:20
Split DateApr 17, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.30.41M
Float28.20M
Insiders1.38%
Institutions19.36%
Short Interest
Short Ratio0.3d
Short % Float0.31%
Short % Out.0.26%
Shares Short83.72K
Short (prev mo.)156.38K
Technical
SMA 501.079 (+17.7%)
SMA 2001.114 (+14.0%)
Beta0.01
S&P 52W Chg16.45%
Avg Vol (30d)758.17K
Avg Vol (10d)1.31M
Technical Indicators
RSI (14)52.9
MACD0.0896
MACD Signal0.0932
MACD Hist.-0.0036
BB Upper1.541 USD
BB Middle1.258 USD
BB Lower0.9743 USD
BB Width45.04%
ATR (14)0.1108 USD
Vol Ratio (20d)0.84x